SCHEMBL21356103

SCHEMBL21356103

NC(=O)c1cc(O)cc(C(=O)Nc2cccc3cccnc23)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 7/20 0.65
▸ HDAC6 Q9UBN7 1/20 0.62
▸ RAB9A P51151 4/20 0.62
▸ MEN1 O00255 3/20 0.62
▸ KMT2A Q03164 3/20 0.62
▸ L3MBTL1 Q9Y468 2/20 0.62
▸ NPC1 O15118 2/20 0.62
▸ GAA P10253 2/20 0.61
▸ TDP1 Q9NUW8 1/20 0.61
▸ HTT P42858 1/20 0.61
▸ CASP3 P42574 1/20 0.60
▸ SENP8 Q96LD8 1/20 0.60
▸ SENP7 Q9BQF6 1/20 0.60
▸ SENP6 Q9GZR1 1/20 0.60
▸ MAPT P10636 4/20 0.60
▸ HPGD P15428 2/20 0.60
▸ LMNA P02545 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ TP53 P04637 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28870716 0.87 HDAC6 (0.77) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL21356358 0.84 KDR (0.64) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL24430048 0.81 KDR (0.67) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL29647697 0.80 HDAC6 (0.84) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL19631274 0.80 HDAC6 (0.84) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL29434873 0.79 KDR (1.00) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL6260903 0.79 KDR (1.00) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL15093487 0.79 HDAC6 (0.77) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL28302610 0.77 KDR (0.74) KDRHDAC6RAB9AMEN1KMT2A
SCHEMBL3549883 0.77 CYP1A2 (0.71) KDRHDAC6RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11427544-B2 Histone deacetylase 6 inhibitors and use thereof TAIPEI MEDICAL UNIVERSITY (TW) 2022-08-30 — — US disclosed
US-20190284141-A1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF DCB-USA LLC (US) 2019-09-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190284141-A1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF HDAC1, HDAC11, HDAC7 KDR 4795/4885HDAC6 7/4885RAB9A 3537/4885
US-11427544-B2 Histone deacetylase 6 inhibitors and use thereof HDAC1, HDAC11, HDAC7 KDR 4795/4885HDAC6 7/4885RAB9A 3537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback